Efficient methods of therapy of pediatric functional constipation
https://doi.org/10.21518/2079-701X-2022-16-19-105-109.
Abstract
Constipation holds an important place among the functional gastrointestinal disorders. The following are among the main reasons for the development of functional constipation: alimentary factors, impaired nervous and endocrine regulation (functional immaturity of the colon, perinatal injury of the central nervous system, endocrine disease), psychosomatic factors, hypodynamia, previous intestinal infections, iatrogenic effects, food allergies and anorectal pathology, genetic predisposition. Treatment of constipation should be comprehensive and include lifestyle maneuvers, dietary recommendations, dietary fibres and water schedule, pharmacotherapy, biofeedback, and surgical methods. Stimulant laxatives (sodium picosulfate, bisacodyl) are effective drugs among the medications used to treat constipation. A sodium picosulfate drug is an effective stimulant laxative, which has a triple effect: stimulation of bowel movements, reduction of the evacuation time and softening stools. The efficacy and safety of the drug was studied in a multicenter, parallel, double-blind, randomized, placebo-controlled study in patients with chronic constipation. The article presents our own experience – a clinical observation – of the use of sodium picosulfate. 26 children with chronic constipation aged from 1 to 7 years, who had stool retention from 3 to 7 days, were observed. The inclusion of a stimulant sodium picosulfate laxative in the comprehensive functional chronic constipation therapy in children aged 1 to 7 years at age-specific dosage variances for 7 days showed high clinical efficacy, which resulted in the normalization of stool in 76.9% of children, facilitating bowel movements and improvement of children’s well-being. This drug can be recommended in the comprehensive therapy of functional constipation in children.
About the Authors
T. G. MalanichevaRussian Federation
Tatyana G. Malanicheva, Dr. Sci. (Med.), Professor of the Department of Propaedeutics of Children’s Diseases and Faculty Pediatrics
49, Butlerov St., Kazan, 420012, Russia
N. V. Ziatdinova
Russian Federation
Nelli V. Ziatdinova, Cand. Sci. (Med.), Associate Professor of the Department of Propaedeutics of Children’s Diseases and Faculty Pediatrics
49, Butlerov St., Kazan, 420012, Russia
Ch. I. Ashrafullina
Russian Federation
Chulpan I. Ashrafullina, Head of Pediatric Department No. 1
140, Orenburgskiy Тract St., Kazan, 420138, Russia
References
1. Denisov M.Yu., Yakushin A.S., Gild E.V. (eds.). Defecation disorders in childhood. Tactics and strategy of rehabilitation treatment. Novosibirsk; 2018. 136 р. (In Russ.)
2. Erdes S.I., Matsukatova B.O., Antishin A.S. Episodic and chronic constipation in children: a step-by-step approach to therapy within the framework of the IV Roman Criteria. Pediatrics. Consilium Medicum. 2019;(1):52–57. (In Russ.) Available at: https://cyberleninka.ru/article/n/epizodicheskie-i-hronicheskiezapory-u-detey-poshagovyy-podhod-k-terapii-v-ramkah-iv-rimskih-kriteriev.
3. Pakhomovskaya N.L., Tatianina O.F., Lazareva T.Yu. Functional constipation in children. Meditsinskiy Sovet. 2022;(1):106–113. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-1-106-113.
4. Zakharova I.N., Sugyan N.G., Moskvich I.K. Russian and international recommendations on management of constipations in children. Current Pediatrics. 2014;(1):74–83. (In Russ.) Available at: https://vsp.spr-journal.ru/jour/article/view/229.
5. Mearin F., Lacy B.E., Chang L., Chey W.D., Lembo A.J., Simren M., Spiller R. Bowel Disorders. Gastroenterology. 2016;S0016-5085(16)00222-5. https://doi.org/10.1053/j.gastro.2016.02.031.
6. Bassotti G., De Roberto G., Castellani D., Sediari L., Morelli A. Normal aspects of colorectal motility and abnormalities in slow transit constipation. World J Gastroenterol. 2005;11(18):2691–2696. https://doi.org/10.3748/wjg.v11.i18.2691.
7. Ford A.C., Suares N.C. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: systematic review and meta-analysis. Gut. 2011;60(2):209–218. https//doi.org/10.1136/gut.2010.227132.
8. Mueller-Lissner S., Kamm M.A., Wald A., Hinkel U., Koehler U., Richter E., Bubeck J. Multicenter, 4-week, double-blind, randomized, placebocontrolled trial of sodium picosulfate in patients with chronic constipation. Am J Gastroenterol. 2010;105(4):897–903. https//doi.org/10.1038/ajg.2010.41.
9. Wulkow R., Vix J.-M., Schuijt C., Peil H., Kamm M.A., Jordan C. Randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of the acute use of sodium picosulphate in patients with chronic constipation. Int J Clin Pract. 2007;61(6):944–950. https://doi.org/10.1111/j.1742-1241.2007.01374.x.
10. Bengtsson M. Psychological Well-Being and Symptoms in Women With Chronic Constipation Treated With Sodium Picosulphate. Gastroenterol Nurs. 2005;28(1):3–12. https://doi.org/10.1097/00001610-200501000-00002.
Review
For citations:
Malanicheva TG, Ziatdinova NV, Ashrafullina CI. Efficient methods of therapy of pediatric functional constipation. Meditsinskiy sovet = Medical Council. 2022;(19):105-109. (In Russ.) https://doi.org/10.21518/2079-701X-2022-16-19-105-109.